InvestorsHub Logo

InternetForumUser

07/24/14 12:29 AM

#184065 RE: geocappy1 #184064

I see a lot of posts about PPHM and Gabrilovich; however, there is not much about Gabrilovich and Peregrine Pharmaceuticals. Even according to PPHM, the scientific advisors seemed to have joined to help guide them in the development of Bavituximab. I don't know if preaching about Bavituximab or PPHM would fall under the "Development" Category. Maybe it does but so far, I have not seen anything to show it does.

I wonder if Gabrilovich actually uses the words "Peregrine Pharmaceuticals" or "Bavituximab" in any of his presentations.

With recent scientific insights highlighting bavituximab's immunostimulatory mechanism of action, Peregrine announced today the following additions to its Scientific Advisory Board. The company plans to utilize the expertise of its new advisors to help guide the development of its novel immunotherapeutic candidate bavituximab: